Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Cameroon: Helping Central African Refugees Overcome Trauma Caused by the Massacres
05/24/2015. The coup d’etat that took place in Central African Republic has leaved over than 2.5 millionmillions of people in dire need of assistance.
Connectivity is a lifeline for refugees
01/16/2017. Globally, refugees are 50 per cent less likely than the general population to have an internet-enabled phone, and 29 % of refugee households have no phone at all. This must change, by Filippo Grandi.
UN Secretary-General’s 2019 New Year’s Message
12/29/2018. Video message by United Nations Secretary-General António Guterres for 2019 New Year.
